If you continue without changing your settings, we’ll assume you’re happy to receive all cookies from the BMA website. Find out more about cookies
When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalised web experience.
Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms.
You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
These cookies are required
These cookies allow us to know which pages are the most and least popular and see how visitors move around the site. All information we collect is anonymous unless you actively provide personal information to us.
If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
These cookies allow a website to remember choices you make (such as your user name, language or the region you're in) and tailor the website to provide enhanced features and content for you.
For example, they can be used to remember certain log-in details, changes you've made to text size, font and other parts of pages that you can customise. They may also be used to provide services you've asked for such as watching a video or commenting on a blog. These cookies may be used to ensure that all our services and communications are relevant to you. The information these cookies collect cannot track your browsing activity on other websites.
Without these cookies, a website cannot remember choices you've previously made or personalise your browsing experience meaning you would have to reset these for every visit. In addition, some functionality may not be available if this category is switched off.
Our websites sometimes integrate with other companies’ sites. For example, we integrate with social networking sites such as Twitter and Facebook, to make it easier for you to share what you have read. These sites place their own cookies on your browser as a result of us including their icons and ‘like’ or ‘share’ buttons on our sites.
This week, the BMA published recommendations based on its report Prescribed drugs associated with dependence and withdrawal – building a consensus for action. We have three main calls to action.
The publicity was huge, with headlines on the national news throughout the day and BBC Radio 5 Live devoting the whole of its Sunday morning investigative programme to benzodiazepine dependence, pushing aside another planned story, and I found myself doing a round of TV, radio, and press interviews over a weekend originally set aside for more domestic duties.
Although the BMA’s work, and the recommendations, have been widely welcomed by patient groups and other bodies, a subject as emotive as this was bound to raise strong reactions and two themes kept returning - what took you so long, and why is long-term prescribing continuing?
While it is true that the problems of benzodiazepine dependence have been known for many years, the scale of the problem, and the depth of feeling of those patients involved, has perhaps not been acknowledged.
Although the total number of benzodiazepine prescriptions has been reducing, it is unclear how many of these relate to long-term use, and The University of Roehampton has attempted to calculate this, with a suggested total of over a quarter of a million patients receiving prescriptions for more than six months.
Every patient’s story is different, but many contain similar themes. They describe the bitterness they feel at having been harmed by a medication they thought would help them, and then having this compounded by finding, when they turned to the NHS for help, that the services for them were not there. Indeed, some reported feeling that they were being blamed for their dependence, when actually they had taken the medication as instructed by their doctors.
This situation of blame and mutual distrust benefits nobody, and it was to break this logjam that the BMA begun their work, by looking for areas of agreement, and looking forward to how the current situation might be improved.
So, was I left defending the indefensible, defending the irresponsible and continuing over-prescribing of these drugs in contravention to established guidelines? I don’t think so, no; primarily because defending was never the intention, explaining was.
The number of patients involved is too high, without a doubt, but it represents about half a dozen people per GP, so an individual doctor will sign a couple of repeat prescriptions per week. When mental health issues are the largest single reason for a GP visit, this demonstrates that the clear majority of distressed patients and managed within the current guidance.
Continued prescribing is also in many cases appropriate. It is indefensible to stop these medications abruptly, and reductions done without full agreement and commitment from the patient are doomed to failure, adding to the patient’s misery and feelings of failure and anxiety. Repeat prescriptions is these circumstances are best looked on as harm-reduction maintenance until the patient is ready for change.
We are in some danger of concentrating too much on the final act of prescribing, the pressing of the ‘enter’ key and the spitting out from the printer of the green piece of paper. The prescribing decision is simply the end of a complex interaction between the doctor, the patient, the illness, and society, and while we continue to live in a fragmented unequal world, with poor access to acute mental health services, and with GPs who have less time to spend with their patients than those in other comparable countries, prescribing will continue to be higher than it might.
My hope is that this work will enable doctors and patients to speak together, with one voice, looking to reduce prescribing through the provision of services to help those trapped in this situation, as well as by preventing others beginning what we have heard can be a terrible journey.
Andrew Green is the BMA GPs committee clinical policy lead
For more information visit the BMA website
Hallelujah! I wish this could happen on my side of the pond in the U.S. I can only imagine prescription drug dependency is an equal or even bigger problem here! I hope your experts will be accessed by U.S. stakeholders to help provide adequate support for people here! This is a tragedy that the medical establishment, government and drug companies must stop sweeping under the rug! Donna Kolojeskie - USA
Thank you for this helpful article on an issue which produces conflict in my experience between GPs in practices depending on the involvement they have in seeking to continue to support and treat patients in a holistic way and not just look at prescribing targets. You are right that it relates to time available to spend with patients, listening to their perspective and helping them to build confidence and find better ways to reduce anxiety. An ongoing challenge especially for those in deprived areas.
I am so pleased to see this position coming from the BMA, coming from NI with the highest rate of prescription drug use in the UK, and we have recently found, higher inclusion of prescription drug than illicit drug rates in coroner reports. I am writing up research with prisoners and one of the biggest narratives of participants was being withdrawn off prescribed prescription medication on entry with no supports put in place, whilst being demonised as 'drug seeking'.
Please take a look at the RxISK blog. There is no need to repeating the same data gathering gathering over and over again...there is no mention of looking for a cure for the arms caused to so many people ..Why not? it adds to the cynicism of 'suffers.
I am a very long term nitrazepam and diazepam user. My GP was willing to prescribe me both on condition that I promised never to increase the dosage he agreed to. So the years went by and I kept my promise and my tablets were prescribed on a promised regular basis. That was 30 years ago and I now don't even know if I have taken them. However, if I ever to forget or take less, I feel very ill the following day. I have recently been to hospital and now been told that both the hospital doctor and my GP have decided to SUDDENLY STOP!! After one day. I felt awful but 2 days later, I am feeling disorientated, lost my appetite totally, sweating and feeling sick, with chronic diarreah. Please could you kindly let me know if I have any right to apaeal to his decision? My original doctor, who owns the Practice, has now retired, but sill visits the surgery apparently. Please advise me as I am going through a LIVING HELL - and this total and sudden withdrawal is making me very very ill..... what is your advice please? Anonymous from Central London …………………………..